Management of Hyponatremia with Brain Metastases and Facial Twitching

Immediate Stabilization and Assessment

The American Association of Neurological Surgeons recommends administering 3% hypertonic saline immediately with a target correction of 6 mmol/L over 6 hours or until facial twitching resolves in patients with hyponatremia and brain metastases 1, 2
The National Comprehensive Cancer Network suggests starting dexamethasone 16 mg/day in divided doses for cerebral edema from brain metastases 3, 4
Serum sodium should be checked every 2 hours during the initial correction phase, as recommended by the Neurosurgery society 2, 5
The correction of sodium levels should not exceed 8 mmol/L in 24 hours to prevent osmotic demyelination syndrome, according to the Neurosurgery guidelines 1, 2, 5

The Neuro-Oncology society recommends starting antiepileptic medication immediately as adjunctive therapy alongside hypertonic saline in patients with brain metastases and seizure activity 3
Levetiracetam or lacosamide are preferred antiepileptic medications as they do not induce hepatic enzymes that could affect chemotherapy metabolism, as suggested by the Journal of the National Comprehensive Cancer Network 3, 4
The Journal of Neurology, Neurosurgery and Psychiatry advises avoiding phenytoin in patients with brain pathology due to its association with excess morbidity and mortality 6

The Neurosurgery society recommends obtaining serum and urine osmolality, urine sodium, and urine electrolytes to assess the underlying cause of hyponatremia 1, 7
Assessing volume status clinically by checking for orthostatic hypotension, dry mucous membranes, skin turgor, jugular venous distention, and peripheral edema is crucial, as suggested by the Neurosurgery guidelines 1, 5
The Neurosurgery society advises against obtaining ADH or natriuretic peptide levels as they are not supported by evidence and delay treatment 1, 5

The Neurosurgery society recommends distinguishing between SIADH and cerebral salt wasting based on clinical and laboratory findings, as the treatments are opposite 1, 5
In SIADH, urine sodium is typically >20-40 mmol/L with urine osmolality >300 mOsm/kg, and there are no signs of volume depletion, as described by the Neurosurgery guidelines 1, 2
In cerebral salt wasting, urine sodium is >20 mmol/L despite clinical volume depletion, and orthostatic hypotension, tachycardia, and dry mucous membranes are present, according to the Neurosurgery society 1, 5

The Neurosurgery society recommends implementing fluid restriction to 1 L/day once facial twitching resolves in patients with SIADH 1, 2, 5
The Journal of the National Comprehensive Cancer Network suggests adding oral sodium chloride 100 mEq three times daily if there is no response to fluid restriction 2, 7
The Neurosurgery society advises against using fluid restriction in cerebral salt wasting, as it worsens hypovolemia and outcomes 1, 5

The Neuro-Oncology society recommends continuing dexamethasone 4-8 mg/day for moderate symptoms after the acute phase in patients with brain metastases 3, 4
Higher doses of dexamethasone (up to 100 mg/day) may be needed if there is mass effect or impending herniation, as suggested by the Journal of the National Comprehensive Cancer Network 4, 8
The Neuro-Oncology society advises tapering steroids as quickly as clinically possible to minimize toxicity 3, 4

The Neurosurgery society recommends never using fluid restriction as initial treatment for symptomatic hyponatremia with neurological symptoms, as it is a medical emergency requiring hypertonic saline 1, 2
The Neurosurgery society advises never exceeding 8 mmol/L correction in 24 hours, as overcorrection risks osmotic demyelination syndrome with devastating neurological consequences 1, 2, 5
The Neurosurgery society recommends never using fluid restriction in cerebral salt wasting, as it worsens hypovolemia and outcomes 1, 5

The Neurosurgery society recommends checking serum sodium every 2 hours until facial twitching resolves, then every 4 hours for mild symptoms, and daily once stable 2, 5, 7
The Neurosurgery society advises watching for signs of osmotic demyelination syndrome, typically occurring 2-7 days after rapid correction 7
The Neuro-Oncology society recommends monitoring for steroid-related complications, including hyperglycemia, infection risk, and psychiatric symptoms 3, 4